Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Microsoft has a new machine learning tool to improve weather forecasts

October 14, 2026

Doug Ford says Republicans might ‘pull the carpet’ under Trump if midterms are lost

October 14, 2026

Honey, Xbox shrunk its controller

October 14, 2026

Danielle Smith votes to stay in Canada, urges support for other 9 questions

October 14, 2026

Céline Dion gets her own Barbie inspired by iconic 1998 Oscars look

October 14, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Contract Research and Manufacturing Services (CRAMS) Research Report 2026: $258.36 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Press Release

Contract Research and Manufacturing Services (CRAMS) Research Report 2026: $258.36 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

By News RoomApril 30, 20264 Mins Read
Contract Research and Manufacturing Services (CRAMS) Research Report 2026: 8.36 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, April 30, 2026 (GLOBE NEWSWIRE) — The “Contract Research and Manufacturing Services (CRAMS) Market Report 2026” has been added to ResearchAndMarkets.com’s offering.

The Contract Research and Manufacturing Services (CRAMS) market has experienced substantial growth, expanding from $155.61 billion in 2025 to $171.86 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. This surge is fueled by rising R&D costs in the pharmaceutical sector, a demand for innovative drugs, limited in-house manufacturing capabilities, increasing regulatory complexities, and the emergence of biotechnology companies.

Looking ahead, the CRAMS market is projected to continue its rapid expansion, expected to reach $258.36 billion by 2030, with a CAGR of 10.7%. Factors driving this growth include the increasing adoption of biologics and advanced therapies, the expansion of clinical trial outsourcing, a demand for personalized medicine, advancements in manufacturing automation, and increased contract manufacturing for medical devices. Key trends include the outsourcing of pharmaceutical R&D, the expansion of biologics manufacturing services, growing demand for analytical testing and quality control, growth in custom synthesis and production services, and a rise in contract manufacturing for medical devices.

The aging global population, accompanied by an increase in chronic diseases, acts as a positive influence on the CRAMS market growth forecast. As the geriatric population grows, the prevalence of diseases like cancer, diabetes, Alzheimer’s, and arthritis increases, raising the demand for medicines and, consequently, CRAMS. For instance, the Australian Bureau of Statistics projected a significant rise in population aging, underscoring the increasing demand for CRAMS powered by an aging demographic.

Artificial Intelligence (AI) is becoming a critical utility in the CRAMS market, enhancing operational efficiency. For example, Medidata’s Clinical Data Studio uses AI to improve clinical trial data management, optimizing operations and enhancing data review and reconciliation processes. This innovation illustrates AI’s role in streamlining and optimizing CRAMS processes.

Noteworthy industry moves include Sterling Pharma Solutions’ acquisition of NewChem Technologies Ltd. in October 2023, aimed at enhancing their capabilities in tackling complex process chemistry challenges. This acquisition underscores a trend toward strategic expansions to bolster service offerings in the pharmaceutical industry.

Prominent players in the CRAMS market include Lonza Group, Catalent Inc., WuXi AppTec, Boehringer Ingelheim, and others. North America is the largest CRAMS market region as of 2025, with Asia-Pacific predicted to exhibit faster growth moving forward. Key markets covered include regions like Asia-Pacific, Western Europe, and major countries such as the USA, Germany, China, and India.

Tariffs have affected the CRAMS market by increasing costs for imported raw materials and specialized equipment, notably impacting regions like North America and Asia-Pacific. Despite cost augmentation, these tariffs are prompting local production investments and diversified sourcing strategies, enhancing resilience and cost efficiency in CRAMS operations.

The CRAMS market report provides extensive insights into market statistics, industry size, regional shares, market trends, and opportunities. It offers a comprehensive perspective, analyzing current and future industry scenarios to aid stakeholders in strategic decision-making. Major service offerings include manufacturing and research services, catering to pharmaceutical, biotechnology companies, and academic institutions.

The CRAMS market includes revenues generated by entities through cost optimization and service focus, with market values representing revenues from sales, grants, or donations within defined market geographies. This excludes resale revenues along the supply chain.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2026 – 2030
Estimated Market Value (USD) in 2026 $171.86 Billion
Forecasted Market Value (USD) by 2030 $258.36 Billion
Compound Annual Growth Rate 10.7%
Regions Covered Global


Report Scope

Markets Covered:

  • Services: Manufacturing; Research
  • End User: Pharmaceutical and Biotechnology Companies; Medical Device Companies; Academic Institutes
  • Product: API Services; FDF Services; Biologics Services; Formulation Development & Packaging

Subsegments:

  • Manufacturing: API Manufacturing; FDF Manufacturing; Biologics Manufacturing; Contract Manufacturing of Medical Devices; Formulation Development and Manufacturing; Packaging and Labeling; Testing and Quality Control; Custom Synthesis and Production
  • Research: Preclinical Research; Clinical Research; Drug Discovery; Regulatory Affairs; Bioanalytical Testing; Toxicology Testing; Process Development; Clinical Trial Management; Pharmacovigilance

Key Technologies & Future Trends

  • Biotechnology, Genomics & Precision Medicine
  • Outsourcing of Pharmaceutical R&D
  • Expansion of Biologics Manufacturing Services
  • Increasing Demand for Analytical Testing & Quality Control
  • Growth in Custom Synthesis & Production Services
  • Rising Adoption of Contract Manufacturing for Medical Devices

Companies Featured

  • Lonza Group
  • Catalent Inc.
  • WuXi AppTec
  • Boehringer Ingelheim
  • Charles River Laboratories
  • Jubilant Life Sciences
  • PRA Health Sciences
  • Syngene International Ltd.
  • Samsung Biologics
  • Evotec AG
  • AMRI (Albany Molecular Research Inc.)
  • Parexel International Corporation
  • ICON plc
  • IQVIA Holdings Inc.
  • PPD (Pharmaceutical Product Development)
  • Recipharm AB
  • Curia Global Inc.
  • Cambrex Corporation
  • Labcorp Drug Development
  • CordenPharma
  • Medpace Holdings Inc.
  • FAMAR Health Care Services
  • Rentschler Biopharma SE
  • PCI Pharma Services
  • Dishman Carbogen Amcis Ltd.
  • Thermo Fisher Scientific Inc.
  • ProPharma Group
  • Siegfried AG

For more information about this report visit https://www.researchandmarkets.com/r/vrjk2r

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Contract Research and Manufacturing Services (CRAMS) Market

            
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

vineyard vines Returns as Official Style of the Head Of The Charles® Regatta

Bigger & Better Than Ever: Laxmi & Chef Kunal Kapur Return With ‘Diwali Delights’ Season 2

2026 Chery International User Summit to Kick Off: LUXEED Set for Global Brand Launch

Going Asset Management Wins Capital’s Excellence Fund Award, Harnessing Technology to Enhance the Long-Term Value of Assets

Alation Honors 2026 AI Radicals Award Winners at revAlation

Supported Employment: Helping Individuals Build Meaningful Careers

“The Carbon Pursuit of Happiness” Premieres October 10: A New Chapter for In-Depth Dialogue on Health and Humanity

Evolution Metals & Technologies Corp. Raises Fiscal 2026 Revenue Guidance 62% at Midpoint to 11 Million and Reaffirms 460 Million Fiscal 2027 Outlook

Ufunded Launches “Spotlight” Series, Documenting the Minds Shaping Modern Trading

Editors Picks

Doug Ford says Republicans might ‘pull the carpet’ under Trump if midterms are lost

October 14, 2026

Honey, Xbox shrunk its controller

October 14, 2026

Danielle Smith votes to stay in Canada, urges support for other 9 questions

October 14, 2026

Céline Dion gets her own Barbie inspired by iconic 1998 Oscars look

October 14, 2026

Latest News

OpenAI claims an ex-employee took its product plans and presented them to Apple

October 14, 2026

Major projects CEO faces B.C. First Nations’ frustrations over lack of consultations

October 14, 2026

The best feature of Apple’s HomeView might be its simplicity

October 14, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version